Literature DB >> 12399768

Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines.

Neera Agarwal-Antal1, Glen M Bowen, John W Gerwels.   

Abstract

BACKGROUND: Obtaining clear margins of resection of lentigo maligna (LM), a subtype of melanoma in situ, from sun-damaged skin of the head and neck continues to be a surgical challenge. The margins may be uncertain both clinically and histologically, causing difficulty in determining the surgical excision perimeter.
OBJECTIVE: We sought to determine whether the current National Institutes of Health consensus conference (1992) recommendation of 5-mm margins is adequate for the removal of LM and to evaluate at what stage tumor-free margins are ultimately attained by using polygonal, staged excisions.
METHODS: Ninety-two cases of LM were evaluated and treated in a university tertiary care setting. Straight-edge polygonal resections in a staged fashion of LM variants of MIS were evaluated by means of permanent serial histopathologic sections. Each stage of resection used a 5-mm margin. Specimens were color-coded and mapped. Any sites of tumor at resected margins were identified by a dermatopathologist and noted on the map of the excised specimen. Positive margins and areas with markedly atypical melanocytes were further resected, color-coded, mapped, and evaluated as previously described until margins free of tumor were attained.
RESULTS: The patient distribution was 37% female and 63% male, with ages ranging from 24 to 100 years (median age, 70 years). Sixty-nine patients had a biopsy-proven diagnosis of LM involving the head and neck (75%), and 23 patients (25%) had LM elsewhere. Thirty-nine patients (42%) were tumor-free after one stage, 25 (27%) required 2 stages, 14 (15%) required 3 stages, 6 (7%) required 4 stages, and 8 (9%) needed 5 or more stages to achieve tumor-free margins. The central portion of the submitted polygonal excisions revealed an invasive component in 16% of cases.
CONCLUSIONS: Use of polygonal perimeter excisions with serial histopathologic permanent sections in a staged fashion is an accurate and thorough method of evaluating and treating LM. This study demonstrates that the standard recommendation of 5-mm margins is adequate in less than 50% of cases and reiterates the need for the careful evaluation of peripheral margins in LM. Because an invasive component can be present and would alter recommended surgical depths and margins, all of the tumor should be submitted at the first stage rather than peripheral margins only.

Entities:  

Mesh:

Year:  2002        PMID: 12399768     DOI: 10.1067/mjd.2002.124085

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  21 in total

1.  Handheld reflectance confocal microscopy to aid in the management of complex facial lentigo maligna.

Authors:  Brian P Hibler; Oriol Yélamos; Miguel Cordova; Heidy Sierra; Milind Rajadhyaksha; Kishwer S Nehal; Anthony M Rossi
Journal:  Cutis       Date:  2017-05

2.  Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision.

Authors:  Jessica M Donigan; Mark A Hyde; David E Goldgar; Michael L Hadley; Marianne Bowling; Glen M Bowen
Journal:  JAMA Dermatol       Date:  2018-08-01       Impact factor: 10.282

3.  Lentigo maligna melanoma with a history of cosmetic treatment: Prevalence, surgical outcomes and considerations.

Authors:  Brian P Hibler; Karen L Connolly; Erica H Lee; Anthony M Rossi; Kishwer S Nehal
Journal:  Lasers Surg Med       Date:  2017-05-29       Impact factor: 4.025

4.  Staged Excision for Lentigo Maligna and Lentigo Maligna Melanoma: Analysis of Surgical Margins and Long-term Recurrence in 68 Cases from a Single Practice.

Authors:  Joshua B Wilson; Hobart W Walling; Richard K Scupham; Andrew K Bean; Roger I Ceilley; Kirsten E Goetz
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

Review 5.  Treatment of periocular lentigo maligna with topical 5% Imiquimod: a review.

Authors:  Inga Neumann; R Patalay; M Kaushik; H Timlin; C Daniel
Journal:  Eye (Lond)       Date:  2022-07-14       Impact factor: 4.456

6.  Melanoma in Situ Treated with Topical Imiquimod for Management of Persistently Positive Margins: A Review of Treatment Methods.

Authors:  Qing Fan; Stephanie Cohen; Becky John; Adam I Riker
Journal:  Ochsner J       Date:  2015

Review 7.  Real-time fluorescence image-guided oncologic surgery.

Authors:  Suman B Mondal; Shengkui Gao; Nan Zhu; Rongguang Liang; Viktor Gruev; Samuel Achilefu
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

Review 8.  Diagnosis and management of lentigo maligna: a review.

Authors:  Julia M Kasprzak; Yaohui G Xu
Journal:  Drugs Context       Date:  2015-05-29

9.  Clinical size is a poor predictor of invasion in melanoma of the lentigo maligna type.

Authors:  Cristian Navarrete-Dechent; Saud Aleissa; Karen Connolly; Brian P Hibler; Stephen W Dusza; Anthony M Rossi; Erica Lee; Kishwer S Nehal
Journal:  J Am Acad Dermatol       Date:  2020-10-20       Impact factor: 11.527

10.  Ten-year Follow-up Study of Grenz Ray Treatment for Lentigo Maligna and Early Lentigo Maligna Melanoma.

Authors:  Iara R T Drakensjö; Einar Rosen; Margareta Frohm Nilsson; Ada Girnita
Journal:  Acta Derm Venereol       Date:  2020-10-06       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.